Although the analysis of transcriptional states of SLC1A5 does not yield prognostic implications, the unequivocal discoveries on the influences of SLC1A5 on the infiltration of multiple immune cell components in the TME of HNSCC/OSCC may substantiate the potential indication of immune therapy. This evidence concerns the gene SLC1A5 and head and neck squamous cell carcinoma.